Cargando…

Impact of COVID-19 pandemic in the activity of a Therapeutic Apheresis unit in Italy

INTRODUCTION: The recent Coronavirus Disease 2019 (COVID-19) outbreak has led to profound and rapid changes in the Italian and Veneto Region Healthcare System. This context also includes the quick reorganization which the Apheresis Unit (AU) of the Padova University Hospital, i.e. the Regional Refer...

Descripción completa

Detalles Bibliográficos
Autores principales: Colpo, A., Astolfi, L., Tison, T., De Silvestro, G., Marson, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446708/
https://www.ncbi.nlm.nih.gov/pubmed/32912734
http://dx.doi.org/10.1016/j.transci.2020.102925
_version_ 1783574174129717248
author Colpo, A.
Astolfi, L.
Tison, T.
De Silvestro, G.
Marson, P.
author_facet Colpo, A.
Astolfi, L.
Tison, T.
De Silvestro, G.
Marson, P.
author_sort Colpo, A.
collection PubMed
description INTRODUCTION: The recent Coronavirus Disease 2019 (COVID-19) outbreak has led to profound and rapid changes in the Italian and Veneto Region Healthcare System. This context also includes the quick reorganization which the Apheresis Unit (AU) of the Padova University Hospital, i.e. the Regional Reference Center for Therapeutic Apheresis (TA), had to face. MATERIAL AND METHODS: The study retrospectively evaluated the TA activity (procedures performed, patients treated and consultations) during the COVID-19 pandemic, from March to April 2020, comparing the activity in the same time period in 2018 and 2019. RESULTS: In the period analyzed, a significant reduction in both the total number of procedures performed and of patients treated, respectively by 17 % and 16 % for the procedures and by 19 % and 20 % for patients treated compared to the same period of 2018 and 2019, respectively, was observed. A concomitant reduction in requests for TA consultation for new patients (both outpatients and inpatients) was observed, equal to 32 % and 21 % compared to 2018 and 2019, respectively. CONCLUSION: Many reasons determined the observed reduction in the TA activity during the recent COVID-19 outbreak. The AU itself was quickly reorganized in terms of location and supplies to allow for the appropriate COVID-19 patients care. Many non urgent cases, after multidisciplinary discussion between Clinicians and Apheresis Specialists, were deferred, maintaining close phone and e-mail contact with patients.
format Online
Article
Text
id pubmed-7446708
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-74467082020-08-26 Impact of COVID-19 pandemic in the activity of a Therapeutic Apheresis unit in Italy Colpo, A. Astolfi, L. Tison, T. De Silvestro, G. Marson, P. Transfus Apher Sci Article INTRODUCTION: The recent Coronavirus Disease 2019 (COVID-19) outbreak has led to profound and rapid changes in the Italian and Veneto Region Healthcare System. This context also includes the quick reorganization which the Apheresis Unit (AU) of the Padova University Hospital, i.e. the Regional Reference Center for Therapeutic Apheresis (TA), had to face. MATERIAL AND METHODS: The study retrospectively evaluated the TA activity (procedures performed, patients treated and consultations) during the COVID-19 pandemic, from March to April 2020, comparing the activity in the same time period in 2018 and 2019. RESULTS: In the period analyzed, a significant reduction in both the total number of procedures performed and of patients treated, respectively by 17 % and 16 % for the procedures and by 19 % and 20 % for patients treated compared to the same period of 2018 and 2019, respectively, was observed. A concomitant reduction in requests for TA consultation for new patients (both outpatients and inpatients) was observed, equal to 32 % and 21 % compared to 2018 and 2019, respectively. CONCLUSION: Many reasons determined the observed reduction in the TA activity during the recent COVID-19 outbreak. The AU itself was quickly reorganized in terms of location and supplies to allow for the appropriate COVID-19 patients care. Many non urgent cases, after multidisciplinary discussion between Clinicians and Apheresis Specialists, were deferred, maintaining close phone and e-mail contact with patients. Elsevier Ltd. 2020-12 2020-08-25 /pmc/articles/PMC7446708/ /pubmed/32912734 http://dx.doi.org/10.1016/j.transci.2020.102925 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Colpo, A.
Astolfi, L.
Tison, T.
De Silvestro, G.
Marson, P.
Impact of COVID-19 pandemic in the activity of a Therapeutic Apheresis unit in Italy
title Impact of COVID-19 pandemic in the activity of a Therapeutic Apheresis unit in Italy
title_full Impact of COVID-19 pandemic in the activity of a Therapeutic Apheresis unit in Italy
title_fullStr Impact of COVID-19 pandemic in the activity of a Therapeutic Apheresis unit in Italy
title_full_unstemmed Impact of COVID-19 pandemic in the activity of a Therapeutic Apheresis unit in Italy
title_short Impact of COVID-19 pandemic in the activity of a Therapeutic Apheresis unit in Italy
title_sort impact of covid-19 pandemic in the activity of a therapeutic apheresis unit in italy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446708/
https://www.ncbi.nlm.nih.gov/pubmed/32912734
http://dx.doi.org/10.1016/j.transci.2020.102925
work_keys_str_mv AT colpoa impactofcovid19pandemicintheactivityofatherapeuticapheresisunitinitaly
AT astolfil impactofcovid19pandemicintheactivityofatherapeuticapheresisunitinitaly
AT tisont impactofcovid19pandemicintheactivityofatherapeuticapheresisunitinitaly
AT desilvestrog impactofcovid19pandemicintheactivityofatherapeuticapheresisunitinitaly
AT marsonp impactofcovid19pandemicintheactivityofatherapeuticapheresisunitinitaly